About Provisbiolabs
Provisbiolabs is a Healthcare company based in India founded in 2019. It develops and manufactures bioreagents for global pharma and biopharma research and production. It operates on a B2B and D2C model. The company has 32 employees. Its Indian entity Provis Biolabs Private Limited reported revenue of ₹16.57 Cr. Provisbiolabs offers products and services including L-Asparaginase, Pegaspargase, Streptokinase, Sodium Hyaluronate, and Provinase. Its focus areas include Health Tech, Biotechnology, Bioreagents and Recombinant Enzymes.
Company details
Provis Biolabs is a biotechnology company founded in 2019, specializing in premium bioreagents for pharmaceutical and biopharmaceutical uses. It offers end-to-end services from RD to GMP manufacturing, supported by certifications like WHO-GMP and ISO 9001:2015. The company provides scalable production solutions and has launched operations in the USA, focusing on animal origin-free products for life sciences research and therapeutic development, serving global partners.
- Headquarters India
- Employees 32
- SectorsHealthcare
- Website provisbiolabs.com
- Social LinkedIn
- Legal Name Provis Biolabs Private Limited
- Date of Incorporation 12 Sep, 2019
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹16.57 Cr
FY 2025 · -1% YoY
- Net Profit₹1.81 Cr
FY 2025 · 11% margin
- EBITDA₹4.43 Cr
FY 2025 · 27% margin
- Employee Count32
Associated legal entities of Provisbiolabs
Provisbiolabs operates through Provis Biolabs Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Provis Biolabs Private Limited CIN U24290TG2019PTC135389 | Active | 12 Sep 2019 | Hyderabad, Telangana | ₹16.6 Cr | 32 | 2 | View details |
Products & Services of Provisbiolabs
Provisbiolabs offers a comprehensive portfolio of products and services, including L-Asparaginase, Pegaspargase, Streptokinase, Sodium Hyaluronate, and Provinase.
Enzyme for leukemia therapy by depleting asparagine in cancer cells.
Pegylated enzyme for prolonged leukemia treatment activity.
Enzyme used for dissolving blood clots in emergencies.
Lubricant for joint injections to relieve osteoarthritis pain.
Endonuclease enzyme for protein cleavage in research applications.
Enzyme for cell culture and insulin production processes.
Excipient for vaccines and cell culture stability enhancement.
Contract development for pharma production from R&D to commercial scale.
Board of directors of Provis Biolabs Private Limited (Provisbiolabs)
Provis Biolabs Private Limited is the primary company behind Provisbiolabs. The board of Provis Biolabs Private Limited currently have 2 directors; the longest-serving is Nandini Honnur Narayanareddy, appointed in 2019.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nandini Honnur Narayanareddy DIN 08560727 | Director | 12 Sep 2019 | 7 yrs 1 mo | Provis Biolabs Private Limited |
| Balareddy Bheemareddy DIN 08560726 | Director | 12 Sep 2019 | 7 yrs 1 mo | Provis Biolabs Private Limited |
Financials of Provisbiolabs
Figures of Provis Biolabs Private Limited, the primary company behind Provisbiolabs, for FY 2025. Revenue was ₹16.57 Cr (-1% year on year). Net profit was ₹1.81 Cr (11% margin). EBITDA was ₹4.43 Cr (27% margin). Revenue has grown at a compounded annual rate of +60% over three years.
- ₹16.57 CrRevenue · FY 2025 · -1% YoY
- ₹1.81 CrNet profit · 11% margin
- ₹4.43 CrEBITDA · 27% margin
- ₹62.5 LakhPaid-up capital
- 32Employees (provident fund records)
- +60%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Provis Biolabs Private Limited are on its company page.
Detailed financial statements for Provisbiolabs
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Top companies in Clinical Trials & Research Tech
2 companies that operate in the same segment as Provisbiolabs (Clinical Trials & Research Tech) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | USD 50.52 M | 902 | ||
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | USD 4.22 M | 228 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Provisbiolabs
Provisbiolabs was founded in 2019.
Provisbiolabs is headquartered in India.
Provisbiolabs has 32 employees.
The primary company behind Provisbiolabs, Provis Biolabs Private Limited, reported revenue of ₹16.57 Cr for FY 2025, down 1% year on year.
Provis Biolabs is a biotechnology company founded in 2019, specializing in premium bioreagents for pharmaceutical and biopharmaceutical uses. It offers end-to-end services from RD to GMP manufacturing, supported by certifications like WHO-GMP and ISO 9001:2015. The company provides scalable production solutions and has launched operations in the USA, focusing on animal origin-free products for life sciences research and therapeutic development, serving global partners.
Provisbiolabs offers L-Asparaginase, Pegaspargase, Streptokinase, Sodium Hyaluronate, and 4 more products and services.
Provisbiolabs operates through Provis Biolabs Private Limited.
The legal entities of Provisbiolabs currently have 2 directors, including Nandini Honnur Narayanareddy, Balareddy Bheemareddy.